An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Findings support model in which accelerated biological aging of mammary epithelia may underpin breast cancer susceptibility ...
PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
Researchers at City of Hope, a cancer research and treatment organization, and the University of California, Berkeley, have ...
Bottom Line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient’s risk of hepatocellular carcinoma (HCC), ...
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results